Clinical Trials Directory

Trials / Completed

CompletedNCT02286596

Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Homozygous familial hypercholesterolemia (HoFH) is characterized by a six- to eight-fold raise in plasma LDL-cholesterol (LDL-C) concentrations and atherosclerotic coronary artery disease usually occur before the age of 20 if untreated. Lipid apheresis (LA) has been proved to be a reliable method to decrease LDL-C concentrations and therefore decrease cardiovascular disease risk in HoFH. The objective of this crossover study was to compare efficacy of LA performed with heparin-induced extracorporeal LDL precipitation to dextran sulfate adsorption on the reduction of lipids, inflammatory markers, adhesion molecules and LDL particles size in a cohort of HoFH subjects.

Conditions

Interventions

TypeNameDescription
DEVICEheparin-induced extracorporeal LDL precipitationLipid apheresis for 3 hours
DEVICEdextran sulfate adsorptionLipid apheresis for 3 hours

Timeline

Start date
2013-04-01
Primary completion
2013-06-01
Completion
2014-12-01
First posted
2014-11-10
Last updated
2016-03-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02286596. Inclusion in this directory is not an endorsement.